JCR Pharmaceuticals Co Ltd
TSE:4552
JCR Pharmaceuticals Co Ltd
Operating Income
JCR Pharmaceuticals Co Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
J
|
JCR Pharmaceuticals Co Ltd
TSE:4552
|
Operating Income
¥7.8B
|
CAGR 3-Years
16%
|
CAGR 5-Years
21%
|
CAGR 10-Years
16%
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Operating Income
¥464.9B
|
CAGR 3-Years
7%
|
CAGR 5-Years
18%
|
CAGR 10-Years
17%
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Operating Income
¥188B
|
CAGR 3-Years
37%
|
CAGR 5-Years
19%
|
CAGR 10-Years
5%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Operating Income
¥294.7B
|
CAGR 3-Years
13%
|
CAGR 5-Years
32%
|
CAGR 10-Years
3%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Operating Income
¥444.2B
|
CAGR 3-Years
14%
|
CAGR 5-Years
29%
|
CAGR 10-Years
19%
|
|
Astellas Pharma Inc
TSE:4503
|
Operating Income
¥142B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
3%
|
See Also
What is JCR Pharmaceuticals Co Ltd's Operating Income?
Operating Income
7.8B
JPY
Based on the financial report for Dec 31, 2023, JCR Pharmaceuticals Co Ltd's Operating Income amounts to 7.8B JPY.
What is JCR Pharmaceuticals Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
16%
Over the last year, the Operating Income growth was 20%. The average annual Operating Income growth rates for JCR Pharmaceuticals Co Ltd have been 16% over the past three years , 21% over the past five years , and 16% over the past ten years .